Biotech · Private company
Anterogen Co., Ltd.
Track this companyFree. Adds Anterogen Co., Ltd. to your Dealase workspace and tells you when its record changes.
Clinical trials30 recruiting or active
Pipeline programs5From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline5
- ALLO-ASC-DFUPhase 2 · Diabetic Foot UlcerClinicalTrials.gov · fetched Nov 12, 2026
- ALLO-ASC-SHEETPhase 2 · Diabetic Foot UlcerClinicalTrials.gov · fetched Nov 12, 2026
- ALLO-ASC-SHEETPhase 2 · Dystrophic Epidermolysis BullosaClinicalTrials.gov · fetched Nov 12, 2026
- Hydrogel SHEET(Vehicle control)Phase 2 · Diabetic Foot UlcerClinicalTrials.gov · fetched Nov 12, 2026
- Vehicle ControlPhase 2 · Dystrophic Epidermolysis BullosaClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials3
- Study to Evaluate Safety and Efficacy of ALLO-ASC-SHEET in Subjects With Dystrophic Epidermolysis BullosaPHASE2 · UNKNOWN · started May 1, 2023ClinicalTrials.gov NCT05157958 · fetched Nov 12, 2026
- Clinical Study of ALLO-ASC-SHEET in Subjects With Diabetic Wagner Grade II Foot UlcersPHASE2 · UNKNOWN · started Sep 8, 2020ClinicalTrials.gov NCT04497805 · fetched Nov 12, 2026
- Clinical Study of ALLO-ASC-SHEET in Subjects with Diabetic Foot UlcersPHASE2 · COMPLETED · started Jan 2, 2019ClinicalTrials.gov NCT03754465 · fetched Nov 12, 2026